MELISSA HACKETT: Open Payments
NPI 1619241072 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 26 payments from 18 companies in 2025. Trend: 2023 $69 · 2024 $133 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $90 |
| SpringWorks Therapeutics, Inc. | 1 | $76 |
| E.R. Squibb & Sons, L.L.C. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| GENZYME CORPORATION | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $57 |
| BeOne Medicines USA, Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $53 |
| BeiGene USA, Inc. | 1 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
Products named: BRUKINSA, Nubeqa, OGSIVEO, OPDIVO, WAYRILZ, Enhertu, LIBTAYO, Fabhalta.
Industry payments across DE — which companies pay providers there.
